Carl Voegtlin papers, 1958.
Related Entities
There are 2 Entities related to this resource.
Institut national du cancer (É.-U.)
http://n2t.net/ark:/99166/w6m65v6d (corporateBody)
SBIR program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization. Through a competitive awards-based program, SBIR enables small businesses to explore their technological potential and provides the incentive to profit from its commercialization. From the guide to the NCI Small Business Innovation Research Program records, 198?-20?, (History of Medicine...
Voegtlin, Carl, 1879-1960
http://n2t.net/ark:/99166/w6dj6c1b (person)
C. Voegtlin was Chief of the Division of Pharmacology of the National Institute of Health from 1913 to 1940, and Director of Cancer Research, 1937-38. He served as Chief of the National Cancer Institute from 1938 until his retirement in 1943, when he became a consultant to the Manhattan Project at the Univ. of Rochester School of Medicine & Dentistry, New York. Dr. Voegtlin was on the faculty at Rochester from 1946 to 1952. From the description of Miscellaneous Papers, 1918-1949....
